These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 18284706)
21. The relationship between serum p53 autoantibodies and characteristics of human breast cancer. Mudenda B; Green JA; Green B; Jenkins JR; Robertson L; Tarunina M; Leinster SJ Br J Cancer; 1994 Jun; 69(6):1115-9. PubMed ID: 8198980 [TBL] [Abstract][Full Text] [Related]
22. Using protein microarray to identify and evaluate autoantibodies to tumor-associated antigens in ovarian cancer. Ma Y; Wang X; Qiu C; Qin J; Wang K; Sun G; Jiang D; Li J; Wang L; Shi J; Wang P; Ye H; Dai L; Jiang BH; Zhang J Cancer Sci; 2021 Feb; 112(2):537-549. PubMed ID: 33185955 [TBL] [Abstract][Full Text] [Related]
23. Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer. Wang T; Liu H; Pei L; Wang K; Song C; Wang P; Ye H; Zhang J; Ji Z; Ouyang S; Dai L Clin Immunol; 2020 Jan; 210():108262. PubMed ID: 31629809 [TBL] [Abstract][Full Text] [Related]
24. Development of a multiplex autoantibody test for detection of lung cancer. Jia J; Wang W; Meng W; Ding M; Ma S; Wang X PLoS One; 2014; 9(4):e95444. PubMed ID: 24755629 [TBL] [Abstract][Full Text] [Related]
25. Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65. Chen S; Willis J; Maclean C; Ananieva-Jordanova R; Amoroso MA; Brooking H; Powell M; Collins A; Bennett S; Mitchell S; Burne P; Furmaniak J; Smith BR Clin Chim Acta; 2005 Jul; 357(1):74-83. PubMed ID: 15963796 [TBL] [Abstract][Full Text] [Related]
26. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289 [TBL] [Abstract][Full Text] [Related]
27. Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. Shi FD; Zhang JY; Liu D; Rearden A; Elliot M; Nachtsheim D; Daniels T; Casiano CA; Heeb MJ; Chan EK; Tan EM Prostate; 2005 May; 63(3):252-8. PubMed ID: 15538718 [TBL] [Abstract][Full Text] [Related]
28. Serum anti-p53 antibodies in patients with lung cancer. Mack U; Ukena D; Montenarh M; Sybrecht GW Oncol Rep; 2000; 7(3):669-74. PubMed ID: 10767388 [TBL] [Abstract][Full Text] [Related]
29. Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer. Mitsudomi T; Suzuki S; Yatabe Y; Nishio M; Kuwabara M; Gotoh K; Hatooka S; Shinoda M; Suyama M; Ogawa M; Takahashi T; Ariyoshi Y; Takahashi T J Natl Cancer Inst; 1998 Oct; 90(20):1563-8. PubMed ID: 9790550 [TBL] [Abstract][Full Text] [Related]
30. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer. Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959 [No Abstract] [Full Text] [Related]
32. Survivin Autoantibodies Are Not Elevated in Lung Cancer When Assayed Controlling for Specificity and Smoking Status. Broodman I; VanDuijn MM; Stingl C; Dekker LJ; Germenis AE; de Koning HJ; van Klaveren RJ; Aerts JG; Lindemans J; Luider TM Cancer Immunol Res; 2016 Feb; 4(2):165-72. PubMed ID: 26659304 [TBL] [Abstract][Full Text] [Related]
33. Detection of serum autoantibodies to tumor suppressor gene p53 with a new enzyme-linked immunosorbent assay in patients with ovarian cancer. Marx D; Frey M; Zentgraf H; Adelssen G; Schauer A; Kuhn W; Meden H Cancer Detect Prev; 2001; 25(2):117-22. PubMed ID: 11341346 [TBL] [Abstract][Full Text] [Related]
34. Panel of autoantibodies against multiple tumor-associated antigens for detecting gastric cancer. Hoshino I; Nagata M; Takiguchi N; Nabeya Y; Ikeda A; Yokoi S; Kuwajima A; Tagawa M; Matsushita K; Satoshi Y; Hideaki S Cancer Sci; 2017 Mar; 108(3):308-315. PubMed ID: 28064445 [TBL] [Abstract][Full Text] [Related]
35. Serum p53 antibody detection in patients with impaired lung function. Mattioni M; Chinzari P; Soddu S; Strigari L; Cilenti V; Mastropasqua E BMC Cancer; 2013 Feb; 13():62. PubMed ID: 23384026 [TBL] [Abstract][Full Text] [Related]
36. Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer. Tomkiel JE; Alansari H; Tang N; Virgin JB; Yang X; VandeVord P; Karvonen RL; Granda JL; Kraut MJ; Ensley JF; Fernández-Madrid F Clin Cancer Res; 2002 Mar; 8(3):752-8. PubMed ID: 11895905 [TBL] [Abstract][Full Text] [Related]
37. Gold-loaded nanoporous iron oxide nanocubes: a novel dispersible capture agent for tumor-associated autoantibody analysis in serum. Yadav S; Masud MK; Islam MN; Gopalan V; Lam AK; Tanaka S; Nguyen NT; Hossain MSA; Li C; Yamauchi Y; Shiddiky MJA Nanoscale; 2017 Jun; 9(25):8805-8814. PubMed ID: 28627551 [TBL] [Abstract][Full Text] [Related]
38. Serum p53 antibodies as early markers of lung cancer. Lubin R; Zalcman G; Bouchet L; Trédanel J; Legros Y; Cazals D; Hirsch A; Soussi T Nat Med; 1995 Jul; 1(7):701-2. PubMed ID: 7585154 [TBL] [Abstract][Full Text] [Related]
39. The detection of quantitative serum p53 protein in lung cancer. Sen E; Gönüllü U; Akar N Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881 [TBL] [Abstract][Full Text] [Related]
40. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer. Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]